Every figure this model derived for LAB, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 2,276,000 | PaymentsToAcquirePropertyPlantAndEquipment |
2026-06-30 |
| cash | 476,719,000 | CashAndCashEquivalentsAtCarryingValue |
2026-06-30 |
| current assets | 516,867,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 56,802,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 539,971,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 9,000 | InterestPaidNet |
2026-06-30 |
| ocf | -80,300,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 84,597,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 27,091,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up LAB on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | -74.33 |
| current ratio | 10.85 |
| current ratio reported | 9.1 |
| deferred revenue growth | -77.24 |
| dilution pct | 8.04 |
| fcf margin | -97.61 |
| interest cover | -10607.33 |
| operating margin | -112.85 |
| owner earnings margin | -129.63 |
| revenue growth | -4.78 |
| revenue growth per share | -11.87 |
| roic | -118.67 |
| rpo growth | -12.98 |
| rule of 40 | -117.63 |
| sbc pct revenue | 32.02 |
What this model itself distrusts about LAB's figures. Written by the derivation as it ran, not added afterwards.